Exactech Announces FDA Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System
UF Startup Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System.
Alcyone Presents Preclinical Data on Gene Therapy Programs With the Center for Gene Therapy at the Abigail Wexner Research Institute (AWRI) at ASGCT 2022
Sid Martin Client Alcyone Therapeutics Inc. (“Alcyone”), a biotechnology company pioneering next-generation precision gene-based therapies for complex neurological conditions, presented preclinical data showing the Company’s partnered novel adeno associated virus serotype 9 (AAV9) gene therapy vector ACTX-101 safely and effectively reactivates the inactive X chromosome in a Rett syndrome mouse model and is safe in a preliminary nonhuman primate study at the American Society of Gene & Cell Therapy (ASGCT) 25th Annual Meeting.
UF Neuroscience Students Lead Creation of New Mouse Model for Alzheimer’s Research
A research team led by University of Florida neuroscience graduate students has devised a new mouse model to study the protein tau, which can abnormally accumulate inside neurons and is associated with Alzheimer’s disease and related dementias.
AGTC Announces Positive Three-Month Interim Results From Skyline Trial of AGTC-501 for the Treatment of X-Linked Retinitis Pigmentosa
UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a clinical stage biotechnology company focused on the development of adeno-associated virus (AAV)-based gene therapies for the treatment of rare and debilitating diseases with an initial focus on inherited retinal diseases, today reported positive three-month interim data from its ongoing Phase 2 Skyline trial of AGTC-501, a recombinant AAV viral vector-based gene therapy targeting mutations in the RPGR gene in patients with X-linked retinitis pigmentosa (XLRP).
Cannabix Technologies Correlates THC in Breath and Blood Using Proprietary Sample Collection and Analysis Hardware in Experimental Study
UF startup Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace reports it has successfully tested a supplemental version of its FAIMS technology for detection of ∆9-tetrahydrocannabinol (“THC”) and related analytes in human breath in an independent experimental study.
UF Study: Post-COVID Mortality Risk May Be Caused by Effects of High Inflammation During Illness
A University of Florida study sheds new light on the reason people who recover from a bout of severe COVID-19 are still at increased risk for death in the year after their recovery. The culprit may be high levels of inflammation during the initial illness.
UF First Among US Public Universities in Tech Transfer for Economic Return
The University of Florida ranks first among public universities and second nationwide in a new report that evaluates which U.S. universities are best at moving new discoveries from the lab and into the real world through research commercialization and STEM graduates.
CITI Program and Biotility at UF Announce Partnership
The Collaborative Institutional Training Initiative (CITI Program), the leader in online research, ethics, and compliance training, and Biotility at the University of Florida announced an exclusive licensing agreement to offer select Biotility’s biotech training courses on CITI Program’s learning platform.
A First: Scientists Grow Plants in Soil From the Moon
Scientists have grown plants in soil from the moon, a first in human history and a milestone in lunar and space exploration. In a new paper published in the journal “Communications Biology,” University of Florida researchers showed that plants can successfully sprout and grow in lunar soil. Their study also investigated how plants respond biologically to the moon’s soil, also known as lunar regolith, which is radically different from soil found on Earth.
UF Scripps Researcher’s Drug-Discovery Method Shows Promise Against Aggressive Breast Cancer
UF Scripps Biomedical Research scientist Matthew Disney, Ph.D. has found yet another groundbreaking approach to a problem that has long vexed scientists: How to cure diseases by targeting key RNA. Until now, RNA has been an elusive target for drug discovery. Discoveries made by Disney and his collaborators have rewritten that dogma.